ArticleBritish journal of pharmacology2007

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

G Pryce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.